Alector (ALEC) Non-Current Assets (2018 - 2026)
Alector's (ALEC) quarterly Non-Current Assets came in at $24.8 million in Q1 2026, down 40.38% year-on-year from $41.7 million in Q1 2025, and down 7.29% on a QoQ basis from $26.8 million in Q4 2025.
Alector (ALEC) Non-Current Assets (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Non-Current Assets data on file, last reported at $24.8 million in Q1 2026.
- On a quarterly basis, Non-Current Assets fell 40.38% year-over-year to $24.8 million in Q1 2026; TTM through Mar 2026 was $123.8 million, a 32.31% decrease from a year earlier, with the FY2025 full-year figure at $26.8 million, down 38.41% from the prior year.
- Non-Current Assets for Q1 2026 stood at $24.8 million, down from $26.8 million in the prior quarter.
- Over the last five years, Non-Current Assets for ALEC reached as high as $63.5 million in Q1 2022 and fell as low as $24.8 million in Q1 2026.
- Historically, Non-Current Assets has averaged $49.9 million across 5 years, with a median of $54.1 million in 2024.
- Across the five-year window, Non-Current Assets dropped 1.87% in 2023 and slumped 40.38% in 2026, its largest moves.
- Year by year, Non-Current Assets stood at $61.2 million in 2022, then slipped by 8.48% to $56.0 million in 2023, then fell by 22.37% to $43.5 million in 2024, then sank by 38.41% to $26.8 million in 2025, then fell by 7.29% to $24.8 million in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $24.8 million in Q1 2026, $26.8 million in Q4 2025, and $34.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 5.83 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.95 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 3.95 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 285.82 Mn |
| 10 | Alector | 164.78 Mn | -41.74 Mn | - | 24.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.83 Mn |
| Dec 31, 2025 | 26.79 Mn |
| Sep 30, 2025 | 34.90 Mn |
| Jun 30, 2025 | 37.24 Mn |
| Mar 31, 2025 | 41.65 Mn |
| Dec 31, 2024 | 43.49 Mn |
| Sep 30, 2024 | 46.66 Mn |
| Jun 30, 2024 | 51.03 Mn |
| Mar 31, 2024 | 54.10 Mn |
| Dec 31, 2023 | 56.02 Mn |
| Sep 30, 2023 | 59.25 Mn |
| Jun 30, 2023 | 60.75 Mn |
| Mar 31, 2023 | 62.34 Mn |
| Dec 31, 2022 | 61.21 Mn |
| Sep 30, 2022 | 62.08 Mn |
| Jun 30, 2022 | 62.65 Mn |
| Mar 31, 2022 | 63.53 Mn |
| Dec 31, 2021 | 64.95 Mn |
| Sep 30, 2021 | 66.21 Mn |
| Jun 30, 2021 | 67.78 Mn |